Literature DB >> 27533521

Cenderitide: a multivalent designer-peptide-agonist of particulate guanylyl cyclase receptors with considerable therapeutic potential in cardiorenal disease states.

Johann Wojta1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 27533521     DOI： 10.1093/ehjcvp/pvv043

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Pharmacother


× No keyword cloud information.
  3 in total

Review 1.  Computational Studies of Snake Venom Toxins.

Authors:  Paola G Ojeda; David Ramírez; Jans Alzate-Morales; Julio Caballero; Quentin Kaas; Wendy González
Journal:  Toxins (Basel)       Date:  2017-12-22       Impact factor: 4.546

Review 2.  Resetting the neurohormonal balance in heart failure (HF): the relevance of the natriuretic peptide (NP) system to the clinical management of patients with HF.

Authors:  Speranza Rubattu; Filippos Triposkiadis
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

3.  A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure.

Authors:  Rika Kawakami; Candace Y W Lee; Christopher Scott; Kent R Bailey; John A Schirger; Horng H Chen; Sherry L Benike; Valentina Cannone; Fernando L Martin; S Jeson Sangaralingham; Tomoko Ichiki; John C Burnett
Journal:  Clin Pharmacol Ther       Date:  2018-01-11       Impact factor: 6.875
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.